The Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) definition of clinical remission in gout
- 18 June 2025
- journal article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 85 (1) , 186-194
Abstract
No abstract availableKeywords
Funding Information
- University of Auckland
This publication has 24 references indexed in Scilit:
- Baseline Dual‐Energy Computed Tomography Urate Volume Predicts Fulfillment of Gout Remission After Two Years of Urate‐Lowering TherapyArthritis Care & Research, 2024
- The Patient Experience of Gout Remission: A Qualitative StudyACR Open Rheumatology, 2023
- Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome setSeminars in Arthritis and Rheumatism, 2023
- Intensive Serum Urate Lowering With Oral Urate‐Lowering Therapy for Erosive Gout: A Randomized Double‐Blind Controlled TrialArthritis & Rheumatology, 2021
- Gout Flare Severity From the Patient Perspective: A Qualitative Interview StudyArthritis Care & Research, 2020
- Gout, Hyperuricemia, and Crystal‐Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in GoutArthritis Care & Research, 2019
- Brief Report: Validation of a Definition of Flare in Patients With Established GoutArthritis & Rheumatology, 2017
- Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus ExercisesArthritis Care & Research, 2015
- “You want to get on with the rest of your life”: a qualitative study of health-related quality of life in goutClinical Rheumatology, 2015
- The Brief Illness Perception QuestionnaireJournal of Psychosomatic Research, 2006